Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction

被引:88
作者
Friberg, L
Drvota, V
Bjelak, AH
Eggertsen, G
Ahnve, S [1 ]
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Dept Cardiol, S-14186 Huddinge, Sweden
[2] Huddinge Univ Hosp, Karolinska Inst, Dept Clin Chem, S-14186 Huddinge, Sweden
[3] Huddinge Univ Hosp, Karolinska Inst, Div Prevent Med, S-14186 Huddinge, Sweden
关键词
D O I
10.1016/S0002-9343(01)00980-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: The thyroid hormone system may be downregulated temporarily in patients who are severely ill. This "euthyroid sick syndrome" may be an adaptive response to conserve energy. However, thyroid hormone also has beneficial effects on the cardiovascular system, such as improving cardiac function, reducing systemic vascular resistance, and lowering serum cholesterol levels. We investigated whether thyroid hormone levels obtained at the time of myocardial infarction are associated with subsequent mortality. PATIENTS AND METHODS: Serum levels of thyroid hormones (triiodothyronine [T-3], reverse T-3, free thyroxine [T-4], and thyroid-stimulating hormone) were measured in 331 consecutive patients with acute myocardial infarction (mean age [+/- SD], 68 +/- 12 years), from samples obtained at the time of admission. RESULTS: Fifty-three patients (16%) died within 1 year, Ten percent (16 of 165) of patients with reverse T-3 levels (an inactive metabolite) >0.41 nmol/L (the median value) died within the first week after myocardial infarction, compared with none of the 166 patients with lower levels (P <0.0004). After 1 year, the corresponding figures were 24% (40 of 165) versus 7.8% (13 of 166; P <0.0001). Reverse T-3 levels >0.41 nmol/L were associated with an increased risk of 1-year mortality (hazard ratio = 3.0; 95% confidence interval: 1.4 to 6.3; P = 0.005), independent of age, previous myocardial infarction, prior angina, heart failure, serum creatinine level, and peak serum creatine kinase-MB fraction levels. CONCLUSION: Determination of reverse T-3 levels may be a valuable and simple aid to improve identification of patients with myocardial infarction who are at high risk Of Subsequent mortality. Am J Med. 2001;111:699-703. (C) 2001 by Excerpta Medica, Inc.
引用
收藏
页码:699 / 703
页数:5
相关论文
共 25 条
  • [1] 1ST MYOCARDIAL-INFARCTION - AGE AND EJECTION FRACTION IDENTIFY A LOW-RISK GROUP
    AHNVE, S
    GILPIN, E
    DITTRICH, H
    NICOD, P
    HENNING, H
    CARLISLE, J
    ROSS, J
    [J]. AMERICAN HEART JOURNAL, 1988, 116 (04) : 925 - 932
  • [2] LIMITATIONS AND ADVANTAGES OF THE EJECTION FRACTION FOR DEFINING HIGH-RISK AFTER ACUTE MYOCARDIAL-INFARCTION
    AHNVE, S
    GILPIN, E
    HENNING, H
    CURTIS, G
    COLLINS, D
    ROSS, J
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1986, 58 (10) : 872 - 878
  • [3] THYROID-FUNCTION IN NONTHYROIDAL ILLNESSES
    CHOPRA, IJ
    HERSHMAN, JM
    PARDRIDGE, WM
    NICOLOFF, JT
    [J]. ANNALS OF INTERNAL MEDICINE, 1983, 98 (06) : 946 - 957
  • [4] ACUTE CELLULAR ACTIONS OF THYROID-HORMONE AND MYOCARDIAL-FUNCTION
    DAVIS, PJ
    DAVIS, FB
    [J]. ANNALS OF THORACIC SURGERY, 1993, 56 (01) : S16 - S23
  • [5] BIOCHEMICAL BASIS OF THYROID-HORMONE ACTION IN THE HEART
    DILLMANN, WH
    [J]. AMERICAN JOURNAL OF MEDICINE, 1990, 88 (06) : 626 - 630
  • [6] THE SICK EUTHYROID SYNDROME - CHANGES IN THYROID-HORMONE SERUM PARAMETERS AND HORMONE METABOLISM
    DOCTER, R
    KRENNING, EP
    DEJONG, M
    HENNEMANN, G
    [J]. CLINICAL ENDOCRINOLOGY, 1993, 39 (05) : 499 - 518
  • [7] TRIIODOTHYRONINE-ENHANCED LEFT-VENTRICULAR FUNCTION AFTER ISCHEMIC-INJURY
    DYKE, CM
    YEH, T
    LEHMAN, JD
    ABDELFATTAH, A
    DING, M
    WECHSLER, AS
    SALTER, DR
    [J]. ANNALS OF THORACIC SURGERY, 1991, 52 (01) : 14 - 19
  • [8] CHANGES IN THYROID-HORMONE PARAMETERS AFTER ACUTE MYOCARDIAL-INFARCTION
    EBER, B
    SCHUMACHER, M
    LANGSTEGER, W
    ZWEIKER, R
    FRUHWALD, FM
    POKAN, R
    GASSER, R
    EBER, O
    KLEIN, W
    [J]. CARDIOLOGY, 1995, 86 (02) : 152 - 156
  • [9] THYROID STATUS IN PATIENTS AFTER ACUTE MYOCARDIAL-INFARCTION
    FRANKLYN, JA
    GAMMAGE, MD
    RAMSDEN, DB
    SHEPPARD, MC
    [J]. CLINICAL SCIENCE, 1984, 67 (06) : 585 - 590
  • [10] Thyroid hormone and cardiovascular disease
    Gomberg-Maitland, M
    Frishman, WH
    [J]. AMERICAN HEART JOURNAL, 1998, 135 (02) : 187 - 196